Marks & Spencer Group plc buy krebskrebs
Start price
29.06.20
/
50%
€1.13
Target price
04.11.21
€1.40
Performance (%)
99.82%
End price
05.11.21
€2.26
Summary
This prediction ended on 05.11.21 with a price of €2.26. The BUY prediction by krebskrebs for Marks & Spencer Group plc saw massive gains of 99.82%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marks & Spencer Group plc | 0.000% | 0.000% | -5.393% | 85.650% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
Comments by krebskrebs for this prediction
In the thread Marks & Spencer Group plc diskutieren
Buy mit Kursziel 1,4
In the thread Trading Marks & Spencer Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

